Position in INCY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,032,427
+$245,283 QoQ
Shares Held
21,594
+19.3% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Advisors Asset Management, Inc. holds $38,396,219 across 40 Biotechnology names. INCY ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,300 | $10,850,922 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
177,703 | $4,399,926 | |
| 3 | ASND |
Ascendis Pharma A/S
|
12,200 | $2,790,506 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,085 | $2,383,594 | |
| 5 | INCY |
Incyte Corp
This page
|
21,594 | $2,032,427 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
79,116 | $1,863,972 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
18,718 | $1,627,904 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
6,948 | $1,387,168 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,032,427 | 21,594 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,787,144 | 18,094 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,332,449 | 15,711 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,056,503 | 15,514 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $818,514 | 13,518 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $805,010 | 11,655 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,007,628 | 15,244 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $900,691 | 14,858 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,366,311 | 23,983 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,388,538 | 22,114 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,368,455 | 23,688 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,433,617 | 23,030 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,703,331 | 23,569 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,807,681 | 22,506 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,000,066 | 15,007 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,097,234 | 14,443 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,318,927 | 16,607 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $1,576,044 | 21,472 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,632,974 | 23,742 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,236,764 | 26,587 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $2,190,063 | 26,948 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $2,373,858 | 27,292 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,139,401 | 23,840 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,998,511 | 19,222 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,018,848 | 13,913 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||